CollPlant Biotechnologies... (CLGN)
3.34
0.20 (6.37%)
At close: Mar 07, 2025, 3:43 PM
3.04
-8.95%
After-hours: Mar 06, 2025, 02:03 PM EST
CollPlant Biotechnologies Ltd. Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Net Income | -7.02M | -16.93M | 237K | -5.77M | -11.16M | -3.69M | -6.01M | -7.25M | -4.78M | -3.34M | -4.73M | -4.6M |
Depreciation & Amortization | 1.1M | 1.08M | 773K | 660K | 539K | 390.84K | 302.11K | 224.61K | 201.86K | 205.96K | 273.08K | 326.82K |
Stock-Based Compensation | 1.94M | 2.17M | 1.6M | 1.67M | 1.13M | 1.37M | 1.43M | 928.61K | 1.05M | 52.65K | 132.66K | 489.57K |
Other Working Capital | 93K | -592K | -761K | 36K | -344K | 2.24M | -252.33K | 542.3K | -375.29K | -34.16K | 388.51K | -99.84K |
Other Non-Cash Items | 369K | 521K | -28K | 173K | 3.61M | -407.04K | 18.13K | 42.9K | -256.17 | -8.99K | -7.18K | -43.9K |
Deferred Income Tax | n/a | n/a | -294K | -60K | -62K | 2.53 | n/a | n/a | -26.64K | -143.81K | 89.59K | 11.51K |
Change in Working Capital | 848K | -544K | 216K | -1.12M | 247K | 1.09M | -888.19K | 1.02M | -156.52K | -89.11K | 438.19K | -47.65K |
Operating Cash Flow | -2.76M | -13.7M | 2.5M | -4.45M | -5.7M | -1.24M | -5.15M | -5.04M | -3.71M | -3.33M | -3.8M | -3.86M |
Capital Expenditures | -954K | -1.32M | -1.59M | -519K | -1.49M | -792.05K | -128.61K | -127.91K | -355.82K | -86.29K | -136.11K | -120.99K |
Acquisitions | n/a | -30.2M | 33K | n/a | 30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -20M | -30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 50.24M | -33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -202K | 30.2M | 33K | -82K | 30K | -164.62K | n/a | n/a | n/a | -15.67K | 22.11K | -26.77K |
Investing Cash Flow | -1.16M | 28.92M | -31.56M | -519K | -1.46M | -956.67K | -128.61K | -127.91K | -355.82K | -101.95K | -114K | -147.75K |
Debt Repayment | n/a | n/a | n/a | -24K | -20K | 46K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.11M | 1.87M | 6.02M | 89K | -17K | -70K | 954K | -4.94K | 11.64K | 11.56K | 7.87M | n/a |
Financial Cash Flow | 1.11M | 1.87M | 38.76M | 4.46M | 5.41M | 2.63M | 9.32M | 4.81M | 2.57M | 11.56K | 7.87M | 3.48M |
Net Cash Flow | -3.19M | 16.49M | 9.85M | -445K | -1.69M | 596.89K | 4.03M | -395.15K | -1.47M | -3.27M | 3.87M | -501.88K |
Free Cash Flow | -3.72M | -15.01M | 912K | -4.97M | -7.19M | -2.03M | -5.27M | -5.17M | -4.07M | -3.41M | -3.94M | -3.98M |